Olaratumab + Doxorubicin for Metastatic Soft-Tissue Sarcoma

ANNOUNCE: doxorubicin + olaratumab in advanced soft tissue sarcomasПодробнее

Systemic Therapy Approaches for Soft-Tissue SarcomaПодробнее

Soft Tissue Sarcoma: Role of OlaratumabПодробнее

ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in patients with ad...Подробнее

SPAEN Webinar Experiences with olaratumab in soft tissue sarcomas with Robin Jones, UK 201810021606Подробнее

Dr. Tap on Improved Overall Survival With Olaratumab/Doxorubicin CombinationПодробнее

Overall Survival with OlaratumabПодробнее

Appropriate Patients for Olaratumab + DoxorubicinПодробнее

FDA Approval of Olaratumab + Doxorubicin for STSПодробнее

Olaratumab for LMSПодробнее

Overall Survival with OlaratumabПодробнее